Rachid Izzar - 07 Feb 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Samuel Ntonme, attorney-in-fact for Rachid Izzar
Issuer symbol
BIIB
Transactions as of
07 Feb 2025
Net transactions value
-$164,673
Form type
4
Filing time
11 Feb 2025, 21:52:04 UTC
Previous filing
10 Feb 2025
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +2,043 +39% $0.000000 7,224 07 Feb 2025 Direct F1
transaction BIIB Common Stock Tax liability $84,810 -600 -8.3% $141.35 6,624 07 Feb 2025 Direct
transaction BIIB Common Stock Tax liability $79,863 -565 -8.5% $141.35 6,059 07 Feb 2025 Direct
transaction BIIB Common Stock Options Exercise $0 +1,801 +30% $0.000000 7,860 07 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -2,043 -50% $0.000000 2,044 07 Feb 2025 Common Stock 2,043 $0.000000 Direct F2
transaction BIIB Restricted Stock Unit Options Exercise $0 -1,801 -33% $0.000000 3,604 07 Feb 2025 Common Stock 1,801 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.
F2 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.
F3 The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.